Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 103 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1021 11.3 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Medical University of Vienna Australia 5/2009
Treatment Details: Patients: This phase 3 study involved 1,125 patients with advanced non-small-cell lung cancer. They ranged in age from 18 to 83 years old. There were 490 men and 335 women in this study.
 
1022 11.3 months Metastatic breast cancer 4 Chemotherapy
Royal Free Hospital United Kingdom 3/2010
Treatment Details: Patients: This study involved 40 women with metastatic breast cancer. The median age was 52.1 years. Treatment: Patients were treated with a combination of the chemotherapy agents vino
 
1023 11.3 months Metastatic renal cell carcinoma 4 Chemotherapy
Fox Chase Cancer Center United States 11/2003
Treatment Details: Patients: This Phase II trial involved 21 patients with metastatic renal cell carcinoma; 16 men and 5 women. Median age was 64 years. Eleven patients had undergone previous nephrectomy, se
 
1024 11.3 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Albany Medical Center United States 5/2005
Treatment Details: Patients: This Phase II study involved 39 patients with metastatic or recurrent non-small-cell lung cancer (26 with adenocarcinoma). Twenty-six patients were men, and thirteen were women.
 
1025 11.2 months MPM 5 Chemotherapy
Emory University School of Medicine United States 5/2005
Treatment Details: Patients: This Phase II study involved 33 patients with malignant pleural mesothelioma. Twenty-nine patients were men, and four were women. The median age was 65 years. Twenty-four patien
 
1026 11.2 months Malignant pleural mesothelioma 4 Chemotherapy
Sir Charles Gairdner Hospital Australia 8/2002
Treatment Details: Patients: This Phase II study involved 53 patients with malignant pleural mesothelioma; 45 men and 8 women. The median age was 63 years. Treatment: The treatment consisted of two chemoth
 
1027 11.2 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Johns Hopkins United States 4/2003
Treatment Details: Patients: In the control arm of this Phase III study, there were 110 Patients with newly diagnosed supratentorial glioblastoma multiforme (one patient was classified as having a gliosarcoma)
 
1028 11.2 months Recurrent or progressive GBM 4 Chemotherapy
Azienda Ospedale-Universita Ospedale Busonera Italy 5/2004
Treatment Details: Patients: This Phase II study involved 50 patients with glioblastoma multiforme who had experienced disease recurrence or progression after surgery and standard radiotherapy, and had not bee
 
1029 11.2 months Metastatic melanoma 4 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 6/2011
Treatment Details: Patients: In this study, patients with previously untreated metastatic melanoma were divided into 2 separate treatment groups. Group A consisted of 250 patients with a median age of 57.5 y
 
1030 11.2 months metastatic colorectal cancer 3 Chemotherapy
Sydney Cancer Centre Australia 3/2006
Treatment Details: Patients: This Phase II study involved 55 patients (35 men, 20 women, median age 72) with metastatic colorectal cancer. Two patients had chemotherapy and six had radiotherapy before the stu
 
Page 103 of 187  | Previous Page  | Next Page